Elizabeth L. Cooney
Infectious Disease
789 Howard Ave
Dana Building - 3rd Floor
New Haven, CT 06519
Dana Building - 3rd Floor
New Haven, CT 06519
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B.
Journal: Journal of clinical and translational hepatology
Published: May 01, 2020
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 21, 2019
Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients.
Journal: Frontiers in immunology
Published: March 16, 2017
Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: March 03, 2016
A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1.
Journal: Journal of viral hepatitis
Published: August 08, 2014
Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection.
Journal: Gastroenterology
Published: December 13, 2013
Clinical indicators of immune restoration following highly active antiretroviral therapy.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 23, 2001
Showing 1-9 of 9
Last Updated: 09/26/2026